Delivery Order HHSN261201000004I-HHSN26100002
Award Date
5/12/10
Potential Completion Date
3/31/15
Potential Value
$13K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) for $508,900. The contract is part of the NCI Cancer Genome Atlas Program and requires UNC-CH to provide tissue samples and data from various types of cancer to support the program's goal of comprehensively cataloging genomic changes associated with cancer. The contract has...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Duke University for $270,900.00. The contract is part of the NCI's Cancer Genome Atlas (TCGA) program and is funded through the American Recovery and Reinvestment Act (ARRA). Under this contract, Duke University will provide tissue samples and data from various types of cancer to support the TCGA program. The contract does not have a...
This is a delivery order awarded to the University of North Carolina at Chapel Hill (UNC) under the NCI Genomic Characterization Centers indefinite delivery, indefinite quantity (IDIQ) contract. The order is for RNA sequencing services, with a period of performance from August 31, 2019 to August 30, 2020. The total ceiling value of this order is $4,385,896.69. The National Cancer Institute, a civilian agency within the Department of Health and Human Services, is the funding agency. UNC is a...
This is a $15,850.61 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University of Pittsburgh. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract vehicle, and supports the acquisition of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation. The...
This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Florida (UF) Division of Sponsored Research. The $27,000 firm-fixed-price delivery order supports the Cancer Genome Atlas (TCGA) program, which collects tissue samples and data from various types of cancer. The contract is part of the larger NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract...
This is a $33,756 firm-fixed-price delivery order issued under the National Cancer Institute's Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract. The order was awarded to The Vanderbilt University, a leading private research institution, to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The award is funded through the American Recovery and Reinvestment Act (ARRA) and has an ultimate completion date of September...
This is a $110,445.12 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's cancer research efforts. The contract has no set-aside designation, indicating it was competed openly. The University...
This federal contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the Board of Regents of the University of Nebraska, acting through the University of Nebraska Medical Center (UNMC) Division. The $11,100.00 firm fixed price delivery order contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master indefinite delivery, indefinite quantity (IDIQ) contract. The purpose of this contract is to provide tissue...
This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Regents of the University of California, San Francisco (UCSF) for the Cancer Genome Atlas (TCGA) program. The contract, valued at $24,087.50, is for the acquisition of tissue samples and data from various types of cancer to support the TCGA program, which is part of the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation and is a firm fixed-price type. UCSF, as...
This is a $530,233.58 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services, to the University of Pittsburgh. The contract supports the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA), which aims to collect tissue samples and data from various cancer types. The contract does not have a set-aside designation. The University of Pittsburgh, a large...